Vascular risk assessment in patients with sickle cell disease.
about
Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportChanges in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease.Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.Continuous treatment in multiple myeloma - ready for prime time?Panobinostat for the treatment of multiple myeloma.What's new in the pathophysiology of sickle cell disease?Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.Sickle cell disease: looking back but towards the future.Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.Conjunctival and pulmonary hemodynamic properties in sickle cell disease subjects with and without pulmonary hypertension.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.Increased stroke size following MCA occlusion in a mouse model of sickle cell disease.The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Clinical Predictive Value of Cystatin C in Pediatric Sickle Cell Disease: A Marker of Disease Severity and Subclinical Cardiovascular Dysfunction.
P2860
Q35036717-4B057359-57C0-4CD7-9BA7-1B2E4E69FE7DQ35346284-CAEB0284-7F45-4B4F-8B27-0D93D9662C75Q36030994-CA6DB04E-E2B0-4AD1-A20B-AFFFF83EE7F5Q36354572-86251CFE-6101-48BC-B73F-D0FD775468BAQ36657988-3DEDB97F-A430-4C06-AF51-13587D4DC736Q37936111-527C0032-E818-48DD-AAA6-34B51280AD35Q37992104-86D94978-3488-4AA5-8C16-F6FFD374F5A1Q38097639-06AAC362-7DFA-4D64-BA05-8D8B76102E27Q38918877-BE7F4BBD-1BD9-43C5-8C65-57D904DA0410Q39539610-65BED939-5C45-4C31-A6B8-1D4E74DEABE7Q39806047-41AD3C77-39A5-46A0-B089-377DDF7B0A83Q41849044-54B52E3E-2F68-48F0-B493-88ECA9FAE378Q41975944-0B217631-B329-4389-9C4D-B4BE62F32E00Q42401588-B23CE42E-7900-46BE-83BF-45DFBF67AE1BQ46502955-FB94FA35-466A-4E6F-8E26-F4A695BE266CQ47799282-9B671E5C-075A-4841-A3B1-A680CA1254B1Q51539523-8F0D3035-E303-4608-AA54-EEE136656CE2
P2860
Vascular risk assessment in patients with sickle cell disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Vascular risk assessment in patients with sickle cell disease.
@en
Vascular risk assessment in patients with sickle cell disease.
@nl
type
label
Vascular risk assessment in patients with sickle cell disease.
@en
Vascular risk assessment in patients with sickle cell disease.
@nl
prefLabel
Vascular risk assessment in patients with sickle cell disease.
@en
Vascular risk assessment in patients with sickle cell disease.
@nl
P2860
P1433
P1476
Vascular risk assessment in patients with sickle cell disease.
@en
P2093
Claudia R Morris
P2860
P356
10.3324/HAEMATOL.2010.035097
P577
2011-01-01T00:00:00Z